RE: INDICES> LANTIGEN B (2)

["Christian Doreau" <christian.doreau@pch.ap-hop-paris.fr>]

INDICES> LANTIGEN B (2)
-----------------------

>A combination of bacterial antigens  LANTIGEN B is being marketed in
>Pakistan. Our search has revealed that its marketing was stopped in 1995
>in France. Does anyone have any clues?

Lantigen B has been marketed in France up to 1995.

When the drug was re-evaluated for marketing authorisation in France at that
time, the company decided to stop the marketing and replace it by Biostim.
To our knowledge, this suspension was not due to severe adverse drug
reactions or related problems.

More information (in French) can be find in Biam :
http://cri.ensmp.fr/biam/www/Spe10309.html

I will be happy to give further information if needed

Christian Doreau
SIMP - PCH
7, rue du Fer a Moulin BP 09
F-75221 Paris Cedex 05
tel +33(0)1 46 69 14 41
fax +33(0)1 43 36 92 97
mailto:christian.doreau@pch.ap-hop-paris.fr
http://www.adiph.org


--
Send mail for the `INDICES' conference to `indices@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-indices@usa.healthnet.org'.